EZCORP, Inc.
EZCORP Expects Higher Earnings for June Quarter
Published in Lab Business Week, July 27th, 2008
EZCORP, Inc. (NASDAQ:EZPW) announced that it expects earnings for the quarter ended June 30, 2008 to be approximately $0.25 per share, $0.04 per share better than its previously provided guidance of $0.21 and 56% greater than the $0.16 per share earned for the June 2007 quarter. The expected earnings for the quarter are after the impact of the closure of eleven Florida EZMONEY stores announced on June 17th and the settlement with the Texas Attorney General announced on June 23rd.
For the fourth quarter and fiscal year ending September 30, 2008, EZCORP is raising earnings per share guidance to approximately $0.35 and $1.19. Guidance for the fourth fiscal quarter includes...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2008-07-27)
More Articles from Lab Business Week
- Cancer Gene Therapy
Studies from Cold Spring Harbor Laboratory describe new findings in cancer gene therapy - Heart Attack
SpectraCell Laboratories Offers Additional Test for Heart Attack and Stroke Risk - HIV/AIDS
GeoVax Reports Progress on Its AIDS Vaccine Technology - Lextech Labs
Lextech Labs' iRa Brings Mobile Surveillance to the iPhone - Lextech Labs
Lextech Launches iPhone Focused Sister Company - Life Sciences
Data on life sciences published by researchers at Greenfield Laboratories - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
